Skip to main content
. 2022 Sep 15;308(4):1165–1173. doi: 10.1007/s00404-022-06768-x

Fig. 1.

Fig. 1

Study flow diagram. All discontinuations due to serious adverse events (n = 6) were considered unrelated to trial treatment (preterm birth [n = 1] and missed abortion [n = 1] in the IV iron group and spontaneous abortion [n = 1], preeclampsia [n = 1] and preterm birth [n = 2] in the oral iron group) IV intravenous